Related Experiment Video

Updated: Aug 17, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Penicillin-resistant pneumococcal meningitis: high antibiotic exposure impedes new vaccine protection

L Temime1, P Y Boëlle, A J Valleron

  • 1INSERM U444-Epidémiologie et Sciences de l'Information, Paris, France. laura.temime@sat.ap-hop-paris.fr

Epidemiology and Infection
|June 21, 2005
PubMed

Insights

Pneumococcal conjugate vaccines may not fully prevent meningitis from penicillin-resistant Streptococcus pneumoniae (PRP). High antibiotic exposure can limit vaccine effectiveness, highlighting the need for antibiotic reduction strategies alongside vaccination.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Mathematical Modeling

Background:

  • Increasing incidence of meningitis caused by penicillin-resistant Streptococcus pneumoniae (PRP) poses a significant treatment challenge.
  • Pneumococcal conjugate vaccines are anticipated to mitigate the rise of PRP meningitis.
  • Variations in antibiotic exposure across regions may influence vaccine efficacy.

Purpose of the Study:

  • To evaluate the impact of pneumococcal conjugate vaccines on penicillin-resistant Streptococcus pneumoniae (PRP) meningitis.
  • To assess the role of antibiotic exposure levels in modulating vaccine effectiveness against PRP meningitis.
  • To compare the projected outcomes in the United States and France.

Main Methods:

  • Utilized a mathematical modeling approach.
  • Incorporated current data on antibiotic resistance prevalence.
  • Simulated the impact of vaccination under varying antibiotic exposure scenarios in the US and France.

Main Results:

  • Vaccine effectiveness against PRP meningitis is significantly influenced by the level of antibiotic exposure.
  • In low antibiotic exposure settings (e.g., US), vaccination substantially reduces PRP meningitis cases.
  • In high antibiotic exposure settings (e.g., France), vaccination alone shows limited impact on PRP meningitis incidence.

Conclusions:

  • Antibiotic exposure is a critical factor limiting the effectiveness of pneumococcal conjugate vaccines against PRP meningitis.
  • Reducing antibiotic exposure remains crucial for controlling PRP meningitis, even with widespread vaccine use.
  • Combined strategies of vaccination and antibiotic stewardship are necessary for optimal control of PRP meningitis.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...